These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 28577949)

  • 81. 3D radiomics predicts EGFR mutation, exon-19 deletion and exon-21 L858R mutation in lung adenocarcinoma.
    Liu G; Xu Z; Ge Y; Jiang B; Groen H; Vliegenthart R; Xie X
    Transl Lung Cancer Res; 2020 Aug; 9(4):1212-1224. PubMed ID: 32953499
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Long-term follow-up of a consecutive cohort validating an epidermal growth factor receptor mutation as an independent risk factor for postoperative recurrence in lung adenocarcinoma.
    Matsumura Y; Hayasaka K; Ohira T; Shiono S; Abe J; Notsuda H; Sakurada A; Suzuki H; Okada Y
    Interdiscip Cardiovasc Thorac Surg; 2023 Nov; 37(5):. PubMed ID: 37930012
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Prognostic role of epidermal growth factor receptor mutation status in patients with de novo lung adenocarcinoma.
    Li B; Ren X; Guo H; Guo Y; Han F; Wen X; Wu J; Li X; Ren Y; Hu X; Liu Z
    Transl Cancer Res; 2021 Mar; 10(3):1549-1558. PubMed ID: 35116479
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Computed Tomography Morphological Classification of Lung Adenocarcinoma and Its Correlation with Epidermal Growth Factor Receptor Mutation Status: A Report of 1075 Cases.
    Li Q; He XQ; Fan X; Luo TY; Huo JW; Huang XT
    Int J Gen Med; 2021; 14():3687-3698. PubMed ID: 34321914
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Prognostic factors in completely resected lymph-node-negative pulmonary adenocarcinoma.
    Pakvisal N; Chantranuwat P; Vinayanuwattikun C; Sitthideatphaiboon P; Teerapakpinyo C; Shuangshoti S; Benjacholamas V; Pornpattanarak N; Sriuranpong V
    Transl Cancer Res; 2022 Jul; 11(7):2238-2248. PubMed ID: 35966323
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Clinicopathological features of Chinese lung cancer patients with
    Ning H; Liu M; Wang L; Yang Y; Song N; Xu X; Ju J; Jiang G
    J Thorac Dis; 2017 Mar; 9(3):796-801. PubMed ID: 28449488
    [TBL] [Abstract][Full Text] [Related]  

  • 87. EGFR-Tyrosine Kinase Inhibitor Combined with Radiotherapy in 105 Patients of Lung Adenocarcinoma with Brain Metastasis: A Retrospective Study of Prognostic Factor Analysis.
    Yu W; Xing Y; Song X; Li T; Zhang M
    Oncol Res Treat; 2024; 47(11):531-548. PubMed ID: 39293411
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Targeted Next-Generation Sequencing Analysis Predicts the Recurrence in Resected Lung Adenocarcinoma Harboring
    Kim IA; Hur JY; Kim HJ; Lee SA; Hwang JJ; Kim WS; Lee KY
    Cancers (Basel); 2021 Jul; 13(14):. PubMed ID: 34298845
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Re: Discrepancy of epidermal growth factor receptor mutation in lung adenocarcinoma presenting as multiple ground-glass opacities.
    Stiles B
    Eur J Cardiothorac Surg; 2016 Nov; 50(5):913. PubMed ID: 27530407
    [No Abstract]   [Full Text] [Related]  

  • 90. Impact of smoking on resected lung cancer depends on epidermal growth factor receptor mutation.
    Sekihara K; Kawase A; Matsubayashi Y; Tajiri T; Shibata M; Hayakawa T; Shiiya N; Funai K
    Interdiscip Cardiovasc Thorac Surg; 2024 Jul; 39(1):. PubMed ID: 38851874
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Association of Carbonic Anhydrase 9 Polymorphism and the Epithelial Growth Factor Receptor Mutations in Lung Adenocarcinoma Patients.
    Yu YY; Chiou HL; Tsao SM; Huang CC; Lin CY; Lee CY; Tsao TC; Yang SF; Huang YW
    Diagnostics (Basel); 2020 Apr; 10(5):. PubMed ID: 32365566
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Expression of female sex hormone receptors and its relation to clinicopathological characteristics and prognosis of lung adenocarcinoma.
    Lee JH; Kim HK; Shin BK
    J Pathol Transl Med; 2020 Jan; 54(1):103-111. PubMed ID: 31718122
    [TBL] [Abstract][Full Text] [Related]  

  • 93. [Analysis of Clinical Characteristics of Lung Cancer Combined with 
Multiple Primary Malignancies in Other Organs].
    Zhang S; Xu Z; Dong G; Li M; Xu L
    Zhongguo Fei Ai Za Zhi; 2021 Jan; 24(1):7-12. PubMed ID: 33478184
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Analysis of ultra-deep targeted sequencing reveals mutation burden is associated with gender and clinical outcome in lung adenocarcinoma.
    Xiao D; Pan H; Li F; Wu K; Zhang X; He J
    Oncotarget; 2016 Apr; 7(16):22857-64. PubMed ID: 27009843
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Correlation of pulmonary venous circulating tumor cells with clinicopathological parameters in patients with early-stage lung adenocarcinoma.
    Xu SB; Xie MR; Li CW; Wu XN; Xu MQ
    Transl Cancer Res; 2019 Jun; 8(3):887-898. PubMed ID: 35116828
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Clinical Features and Surgical Treatment of Synchronous Multiple Primary Lung Adenocarcinomas With Different EGFR Mutations.
    Qu R; Ye F; Tu D; Cai Y; Fu X
    Front Oncol; 2021; 11():785777. PubMed ID: 35096585
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Prevalence of epidermal growth factor receptor (EGFR) mutations and correlation with histological patterns in lung adenocarcinoma in patients from Bosnia and Herzegovina.
    Udovičić-Gagula D; Džananović N; Dorić M
    Med Glas (Zenica); 2024 Feb; 21(1):. PubMed ID: 37950662
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Coexisting EGFR and TP53 Mutations in Lung Adenocarcinoma Patients Are Associated With COMP and ITGB8 Upregulation and Poor Prognosis.
    Zheng C; Li X; Ren Y; Yin Z; Zhou B
    Front Mol Biosci; 2020; 7():30. PubMed ID: 32175330
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Differences between low and high grade fetal adenocarcinoma of the lung: a clinicopathological and molecular study.
    Zhang J; Sun J; Liang XL; Lu JL; Luo YF; Liang ZY
    J Thorac Dis; 2017 Jul; 9(7):2071-2078. PubMed ID: 28840008
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Exuberant type 2 pneumocyte hyperplasia: mimic or forerunner of atypical adenomatous hyperplasia?
    Pusiol T; Roncati L; Piscioli F; Barbolini G; Maiorana A
    Histopathology; 2015 Aug; 67(2):267-70. PubMed ID: 25312270
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.